全文获取类型
收费全文 | 3016篇 |
免费 | 223篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 100篇 |
妇产科学 | 76篇 |
基础医学 | 470篇 |
口腔科学 | 105篇 |
临床医学 | 213篇 |
内科学 | 803篇 |
皮肤病学 | 165篇 |
神经病学 | 252篇 |
特种医学 | 62篇 |
外科学 | 232篇 |
综合类 | 4篇 |
预防医学 | 149篇 |
眼科学 | 15篇 |
药学 | 244篇 |
中国医学 | 11篇 |
肿瘤学 | 348篇 |
出版年
2024年 | 2篇 |
2023年 | 37篇 |
2022年 | 57篇 |
2021年 | 128篇 |
2020年 | 82篇 |
2019年 | 119篇 |
2018年 | 107篇 |
2017年 | 96篇 |
2016年 | 87篇 |
2015年 | 116篇 |
2014年 | 152篇 |
2013年 | 150篇 |
2012年 | 249篇 |
2011年 | 272篇 |
2010年 | 130篇 |
2009年 | 137篇 |
2008年 | 214篇 |
2007年 | 178篇 |
2006年 | 169篇 |
2005年 | 191篇 |
2004年 | 163篇 |
2003年 | 139篇 |
2002年 | 97篇 |
2001年 | 21篇 |
2000年 | 22篇 |
1999年 | 22篇 |
1998年 | 16篇 |
1997年 | 16篇 |
1996年 | 15篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 10篇 |
1990年 | 9篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1986年 | 5篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1977年 | 2篇 |
排序方式: 共有3272条查询结果,搜索用时 78 毫秒
61.
62.
63.
64.
65.
Emi Dika Annalisa Patrizi Annalisa Altimari Michelangelo Fiorentino Michelangelo La Placa Elisa Gruppioni 《Cutaneous and ocular toxicology》2015,34(3):251-253
We describe the occurrence of a giant squamous cell carcinoma in a patient receiving vemurafenib for the treatment of late melanoma mestastases. Although the development of keratoacanthomas and squamous cell carcinomas (SCC) has been described during vemurafenib therapy, most of the reported cases are treated with surgical excision. In the present case, SCC regressed after drug withdrawal. 相似文献
66.
67.
Serotonin transporter polymorphism modifies the association between depressive symptoms and sleep onset latency complaint in elderly people: results from the ‘InveCe.Ab’ study
下载免费PDF全文
![点击此处可从《Journal of sleep research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Letizia Polito Annalisa Davin Roberta Vaccaro Simona Abbondanza Stefano Govoni Marco Racchi Antonio Guaita 《Journal of sleep research》2015,24(2):215-222
Previous studies have documented the involvement of the central nervous system serotonin in promoting wakefulness. There are few and conflicting results over whether there is an actual association between bearing the short allele of serotonin transporter promoter polymorphism (5‐HTTLPR) and worse sleep quality. This study examined whether sleep onset latency complaint is associated with the 5‐HTTLPR triallelic polymorphism in the SLC6A4 gene promoter and whether this polymorphism influences the relationship between sleep onset latency complaint and depressive symptoms in elderly people. A total of 1321 community‐dwelling individuals aged 70–74 years were interviewed for sleep onset latency complaint and for sleep medication consumption. Participants’ genomic DNA was typed for 5‐HTTLPR and rs25531 polymorphisms. Depressive symptoms were evaluated with the Geriatric Depression Scale Short form and general medical comorbidity was assessed by the Cumulative Illness Rating Scale. The presence of a past history of depression was recorded. The S′ allele of the 5‐HTTLPR triallelic polymorphism was associated with sleep onset latency complaint. This association was maintained after adjusting for depressive symptoms, sex, age, history of depression and medical comorbidity. After stratification for 5‐HTTLPR/rs25531, only in S′S′ individuals high depressive symptoms were actually associated with sleep onset latency complaint. These data indicate that the low‐expressing 5‐HTTLPR triallelic polymorphism is an independent risk factor for sleep onset latency disturbance. Furthermore, the 5‐HTTLPR genotype influences the association between depressive symptoms and sleep onset latency complaint. 相似文献
68.
Borsi L Balza E Carnemolla B Sassi F Castellani P Berndt A Kosmehl H Biro A Siri A Orecchia P Grassi J Neri D Zardi L 《Blood》2003,102(13):4384-4392
We sought to enhance the selective toxicity of tumor necrosis factor alpha (TNFalpha) to permit its systemic use in cancer therapy. Because ligand-targeted therapeutics have proven successful in improving the selective toxicity of drugs, we prepared a fusion protein (L19mTNFalpha) composed of mouse TNFalpha and a high-affinity antibody fragment (L19 scFv) to the extradomain B (ED-B) domain of fibronectin, a marker of angiogenesis. L19mTNFalpha was expressed in mammalian cells, purified, and characterized. L19mTNFalpha was an immunoreactive and biologically active homotrimer. Radiolabeled L19mTNFalpha selectively targeted tumor neovasculature in tumor-bearing mice, where it accumulated selectively and persistently (tumor-to-blood ratio of the percentage of injected dose per gram [%ID/g] of 700, 48 hours from injection). L19mTNFalpha showed a greater anticancer therapeutic activity than both mTNFalpha and TN11mTNFalpha, a control fusion protein in which an antibody fragment, irrelevant in the tumor model used, substituted for L19. This activity was further dramatically enhanced by its combination with melphalan or the recently reported fusion protein L19-IL2. In conclusion, L19mTNFalpha allows concentrating therapeutically active doses of TNFalpha at the tumor level, thus opening new possibilities for the systemic use of TNFalpha in cancer therapy. 相似文献
69.
Meo A Ruggeri A La Rosa MA Zanghì L Kordes U Fischer R 《European journal of haematology》2005,74(6):523-525
We studied a patient with mild beta-thalassaemia major under treatment with the oral chelator deferiprone (DFP or L1) for about 10 yr (L1 veteran). Due to poor compliance with desferrioxamine, the patient started compassionate use of DFP at an age of 23 yr with a serum ferritin of 5200 microg/L. Monitoring iron overload by SQUID biosusceptometry revealed a dramatic decrease of liver iron concentrations from 4500 to 950 microg/g(liver) within 9.5 yr. A good clinical response to chelation treatment with DFP was observed together with an improvement of liver and cardiac function and a reduction in the hepatitis virus load. 相似文献
70.
Fabrizia Fabrizi de Biani Annalisa Reale Vincenzo Razzano Marco Paolino Germano Giuliani Alessandro Donati Gianluca Giorgi Wojciech Mrz Daniele Piovani Chiara Botta Andrea Cappelli 《RSC advances》2018,8(20):10836
The electrochemical behavior of some polybenzofulvene derivatives bearing bithiophene (BT) or terthiophene (TT) side chains was investigated by cyclic voltammetry. Very interestingly, the presence of unsubstituted terminal thiophene moieties allowed poly-6-BT-BF3k and poly-6-TT-BF3k to be cross-linked by electrochemical procedures. Conductive films were obtained by electrodeposition from solutions of these polymers onto electrode surfaces through the formation of covalent cross-linking due to dimerization (i.e. electrochemical oxidation) of the BT or TT side chains. The films showed electrochromic features and switched from yellow-orange (neutral) to green (positively charged) by switching the potential, and were stable to tenths of cycles, without degradation in the wet state in the electrolyte solution. Finally, the thin film obtained by electrodeposition of poly-6-TT-BF3k on a indium tin oxide (ITO) glass substrate showed in the neutral state a significantly red-shifted photoluminescence (PL) emission (∼40 nm red-shifted with respect to that of the corresponding film obtained by casting procedures), which was consistent with the presence of more conjugated moieties produced by the oxidative dimerization of the TT side chains. The innovative architecture and the easy preparation could lead to a broad range of applications in optoelectronics and bioelectronics for these cross-linked hybrid materials based on π-stacked polybenzofulvene backbones bearing oligothiophene side chains.The electrochemical behavior of some polybenzofulvene derivatives bearing bithiophene (BT) or terthiophene (TT) side chains was investigated by cyclic voltammetry and cross-linked materials were obtained by dimerization of the BT or TT side chains. 相似文献